We are proud to announce that ELZA Institute’s CEO, Nikki L. Hafezi MAS IP ETHZ, will serve as Course Director for a new international program in Uzbekistan — the “Professional Development Course in Visual Sciences and Public Health”.
A new publication in JRS reports the long-term endothelial safety of the ELZA-sub400 protocol for treating progressive keratoconus in corneas thinner than 400 µm.
Transepithelial corneal cross-linking offers a new epi-on CXL protocol with biomechanical outcomes comparable to accelerated epi-off CXL for keratoconus treatment
At first glance, the numbers are reassuring. Over 90% of contact lens wearers in Switzerland feel they’re well-informed about handling their lenses. But ask them
Prof. Farhad Hafezi joins the Academia Ophthalmologica Internationalis at its 50th Anniversary General Assembly in Leiden, June 2025.
Dr. Kaweh Mansouri discusses glaucoma, AI, and modern eye care on Thomas Meyer’s podcast. ELZA Eye Institute Zurich.
Dion Paridaens shared updates at SOE and SECOP 2025, highlighting his and ESOPRS’s role in advancing oculoplastics across Europe.
At the Polish Ophthalmologists Congress, Prof. Farhad Hafezi presented innovative keratoconus treatments ELZA-PACE and ECO-CAIRS in Krakow.
Nikki Hafezi, MAS IP ETHZ led the P21 program in Bukhara, combining keratoconus screening with multidisciplinary pediatric assessments for 400 children.
Dr. Emilio Torres-Netto presented ELZA-PACE cross-linking at BRASCRS 2025, a customised, tissue-preserving keratoconus vision rehabilitation method with promising clinical outcomes.
